Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
about
Aberrant expression of ZNF268 alters the growth and migration of ovarian cancer cellsAltered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrestA dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapyEstrogen regulation of cyclin E2 requires cyclin D1 but not c-MycNovel Molecular Markers for Breast CancerNetwork calisthenics: control of E2F dynamics in cell cycle entryMYC and the art of microRNA maintenanceThe structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent rolesProtein tyrosine phosphatase-like A regulates myoblast proliferation and differentiation through MyoG and the cell cycling signaling pathwayModular patterning of structure and function of the striatum by retinoid receptor signalingDistinct and redundant functions of cyclin E1 and cyclin E2 in development and cancerAssessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.p21cip1 Degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7.Regulation of the G1 phase of the mammalian cell cycle.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Expression of cyclins E1 and E2 during mouse development and in neoplasiaAlterations in gene array patterns in dendritic cells from aged humansStrategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase.Transcriptome analysis of newt lens regeneration reveals distinct gradients in gene expression patterns.Effects of an 11-nm DMSA-coated iron nanoparticle on the gene expression profile of two human cell lines, THP-1 and HepG2Stimulation of hERG1 channel activity promotes a calcium-dependent degradation of cyclin E2, but not cyclin E1, in breast cancer cells.Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formationThe A-type cyclins and the meiotic cell cycle in mammalian male germ cells.Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cellsIn silico search for modifier genes associated with pancreatic and liver disease in Cystic FibrosisA novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.Chitosan dressing promotes healing in third degree burns in mice: gene expression analysis shows biphasic effects for rapid tissue regeneration and decreased fibrotic signaling.Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.Reversing the Warburg effect as a treatment for glioblastoma.AKAP95 promotes cell cycle progression via interactions with cyclin E and low molecular weight cyclin E.Molecular regulation of stem cell quiescence.Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin.A non-redundant function of cyclin E1 in hematopoietic stem cells.FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.Why (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyond.p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.
P2860
Q24317600-C943FDC7-7902-4A28-8B7B-148909A55EE7Q24537257-EA447F93-068D-44B1-8683-1EC23871A19AQ24538802-8C41AF54-D58D-4F93-96D9-515011B5FE18Q24653031-7F3CF907-D682-48A7-B59A-60827B369E63Q26753160-A056690D-4088-49B8-9042-CBD7820145B2Q26824409-49F93F0D-0245-4639-8941-DAB29D62F617Q26825457-8A0DA98C-A6C2-4046-BEF0-C9608BE07AA1Q28303245-C94DC093-6473-418D-A6F5-937FB5F85C07Q28505564-FE4CAA21-16B6-45B8-B7C4-7B242389F1ADQ28507367-17CDE9DE-5A5A-4CB5-AE25-480BE7C761B6Q33715865-7EE31DE3-D1C6-4731-BE09-881FBFC05481Q33762644-F5577C33-A8E6-48CD-80EB-3BCD84296057Q33842575-25D9678D-2313-424B-9960-D9AC7962CFFFQ33892156-C2C713D4-4901-4D04-B286-C23FA42E40D5Q33903965-9EA6A9C6-008D-4C02-AEDB-604EC7FD88FDQ33949158-E437C3D3-D509-4306-8896-ECDEA4D62D9BQ34142273-9AFE2F8F-FDFC-49E4-A2A7-B72E51B7BEAFQ34291542-A16924AD-FF21-4DAB-8873-6986888689CBQ34519903-11104FD1-0A79-4484-B493-9F618F5F3984Q34684392-C7FC0A75-33FA-467C-A741-B5361AB8EC89Q35005026-63D6365B-A8DC-4452-A17A-C4FBBC05F28CQ35176400-E859D776-C8EF-49D7-A898-4DAC1ED1B713Q35421560-FB758B65-D2F9-4C07-B5FB-CD5FEDDF319EQ35843959-04CCD636-58B9-4071-950E-8FF237F139EAQ36175746-CC9AA7E5-45C6-4AE3-840C-B7FBE5836BD2Q36246072-83E99601-F4F8-40BA-8016-130DC6AE5F74Q36322032-68D8B648-E90C-4B06-A295-206E6131DED4Q36326335-E2DF3B7D-40EB-4075-B0D7-72C9A30895A3Q36368387-0BDB543F-71C4-477C-B405-6AC2F3086613Q36674327-C3738135-5788-4E5D-981B-0D74263A8548Q36674332-45CF745F-3509-4D33-A9DD-1805F5C2C7A1Q36725003-28D86AB4-C4F0-4F6E-8486-0E121A320801Q36841253-0B2219C3-00F0-4CFE-A039-6DD5360894F0Q37256787-C2356E0E-8314-46BB-B32D-01371FAA177BQ37315196-EB960482-1148-4EDF-9948-C84BB680A278Q37521401-8B47FE7A-1411-46EB-8BAA-1C1A57BB49E6Q37598769-90AD37FD-BB3B-4C79-9CA3-41B1489A8E00Q38304702-A6763CAE-8B76-4B91-A31E-0623EAB2A73FQ38675849-A8206841-90EE-4CEC-BBCC-E10F1D187BFAQ38733945-1CBDB1FB-0ECF-43FD-A6A0-12FDD5D22C1F
P2860
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
description
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im November 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/11/19)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/11/19)
@nl
наукова стаття, опублікована в листопаді 1998
@uk
مقالة علمية (نشرت في 19-11-1998)
@ar
name
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@ast
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@en
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@nl
type
label
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@ast
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@en
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@nl
prefLabel
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@ast
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@en
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@nl
P2093
P356
P1433
P1476
Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle
@en
P2093
A. R. Beck
J. M. Slingerland
K. Hofmann
L. Richman
P2888
P304
P356
10.1038/SJ.ONC.1202477
P407
P577
1998-11-19T00:00:00Z
P5875
P6179
1022159671